Scinai Immunotherapeutics (SCNI) Interest Coverage Ratio (QoQ) (2014 - 2024)
Scinai Immunotherapeutics (SCNI) Interest Coverage Ratio (QoQ) (2014 - 2024) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Scinai Immunotherapeutics | 352,860.00 | -3.11 Bn | -1.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 179.87% |
| Mar 31, 2023 | 179.38% |
| Dec 31, 2022 | -754.56% |
| Sep 30, 2022 | 194.40% |
| Jun 30, 2022 | -125.25% |
| Mar 31, 2022 | -86.65% |
| Dec 31, 2021 | 805.09% |
| Sep 30, 2021 | 1.96% |
| Jun 30, 2021 | 11.45% |
| Mar 31, 2021 | -87.58% |
| Dec 31, 2020 | 110.78% |
| Sep 30, 2019 | 30,723.45% |
| Jun 30, 2019 | -97.12% |
| Mar 31, 2019 | 104.15% |
| Dec 31, 2018 | -2,434.92% |
| Sep 30, 2018 | -87.98% |
| Jun 30, 2018 | 278.83% |
| Mar 31, 2018 | 212.47% |
| Mar 31, 2016 | -92.70% |
| Dec 31, 2015 | 120.82% |